Evidence map›Paper›PMID 28004818›Full record

ArticleScientific reports2016

3-D Microwell Array System for Culturing Virus Infected Tumor Cells.

Rami El Assal, Umut A Gurkan, Pu Chen, Franceline Juillard, Alessandro Tocchio, Thiruppathiraja Chinnasamy, Chantal Beauchemin, Sebnem Unluisler, Serli Canikyan, Alyssa Holman and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rami El AssalDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Umut A GurkanDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Division for Biomedical Engineering, Division of Infectious Diseases, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Pu ChenDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Franceline JuillardDivision of Infectious Diseases, Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Alessandro TocchioDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Thiruppathiraja ChinnasamyDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Chantal BeaucheminDivision of Infectious Diseases, Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Sebnem UnluislerDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Division for Biomedical Engineering, Division of Infectious Diseases, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Serli CanikyanDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Division for Biomedical Engineering, Division of Infectious Diseases, Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Alyssa HolmanDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Srikar SrivatsaDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Kenneth M KayeDivision of Infectious Diseases, Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Utkan DemirciDemirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Funding

Rapid Fluorescence-Based Determination of Antibiotic SusceptibilityU54EB015408 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI PARRISH, JOHN A, SCHACHTER, STEVEN · 2012 to 2022
$49.2M
GENETIC AND BIOCHEMICAL STUDIES OF THE KSHV LANA GENER01CA082036 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 1999 to 2019
$7.6M
KSHV Latent Infection ReplicationR01DE025208 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 2015 to 2025
$5.3M
Platform technology for detection of cancer-associated viruses in HIV patientsR01DE024971 · NIDCR · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN, KAYE, KENNETH M · 2015 to 2019
$2.1M
Novel disposable microchips for HIV-1 viral loadR01AI093282 · NIAID · STANFORD UNIVERSITY · PI DEMIRCI, UTKAN · 2012 to 2015
$1.7M
Rapid Disease Diagnostics using Photonic Crystal Enhanced Antigen BiomarkerR01GM108584 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ANDERSON, KAREN SUE, CUNNINGHAM, BRIAN T. · 2014 to 2017
$1.6M
Portable Nanostructured Photonic Crystal Device for HIV-1 Viral LoadR01AI120683 · NIAID · STANFORD UNIVERSITY · PI CUNNINGHAM, BRIAN T., DEMIRCI, UTKAN · 2016 to 2019
$1.5M
Single Cell Characterization of Latent HIV-1 ReservoirsR01AI122862 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEMIRCI, UTKAN, HENRICH, TIMOTHY JENSEN · 2016 to 2019
$1.5M
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent ReservoirsR21AI113117 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEMIRCI, UTKAN, HENRICH, TIMOTHY JENSEN · 2014 to 2015
$480k
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single CellsR21AI110277 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEMIRCI, UTKAN, HENRICH, TIMOTHY JENSEN · 2014 to 2015
$474k
NCI NIH HHS R01 CA082036NIAID NIH HHS R01 AI093282NIAID NIH HHS R01 AI120683NIAID NIH HHS R01 AI122862NIAID NIH HHS R21 AI110277NIAID NIH HHS R21 AI113117NIBIB NIH HHS U54 EB015408NIDCR NIH HHS R01 DE024971NIDCR NIH HHS R01 DE025208NIGMS NIH HHS R01 GM108584
6 · The paper itself

Abstract

Cancer cells have been increasingly grown in pharmaceutical research to understand tumorigenesis and develop new therapeutic drugs. Currently, cells are typically grown using two-dimensional (2-D) cell culture approaches, where the native tumor microenvironment is difficult to recapitulate. Thus, one of the main obstacles in oncology is the lack of proper infection models that recount main features present in tumors. In recent years, microtechnology-based platforms have been employed to generate three-dimensional (3-D) models that better mimic the native microenvironment in cell culture. Here, we present an innovative approach to culture Kaposi's sarcoma-associated herpesvirus (KSHV) infected human B cells in 3-D using a microwell array system. The results demonstrate that the KSHV-infected B cells can be grown up to 15 days in a 3-D culture. Compared with 2-D, cells grown in 3-D had increased numbers of KSHV latency-associated nuclear antigen (LANA) dots, as detected by immunofluorescence microscopy, indicating a higher viral genome copy number. Cells in 3-D also demonstrated a higher rate of lytic reactivation. The 3-D microwell array system has the potential to improve 3-D cell oncology models and allow for better-controlled studies for drug discovery.

Indexed as

Gene Expression Regulation, ViralAntigens, ViralB-LymphocytesCell Culture TechniquesCell Line, TumorHerpesvirus 8, HumanHumansNuclear ProteinsViral LoadVirus ActivationVirus LatencyAntigens, Virallatency-associated nuclear antigenNuclear Proteins

Identifiers

PMID28004818
PMCPMC5177905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.